Qiagen
QGEN
292 hedge funds and large institutions have $6.38B invested in Qiagen in 2022 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 105 increasing their positions, 95 reducing their positions, and 46 closing their positions.
212% more call options, than puts
Call options by funds: $95.7M | Put options by funds: $30.7M
11% more repeat investments, than reductions
Existing positions increased: 105 | Existing positions reduced: 95
1.44% less ownership
Funds ownership: 55.49% → 54.04% (-1.4%)
3% less funds holding
Funds holding: 300 → 292 (-8)
13% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 46
14% less capital invested
Capital invested by funds: $7.39B → $6.38B (-$1.01B)
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$70.1M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$49.6M |
| 3 |
NC
Nekton Capital
London,
United Kingdom
|
+$40.6M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$37.5M |
| 5 |
Millennium Management
New York
|
+$34.4M |
Top Sellers
QGEN Hedge Fund Activity: Q1 2022 in Review
292 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Qiagen (QGEN) for Q1 2022, worth a combined $6.38B — down 14% from $7.39B a quarter earlier.
Sellers outnumbered buyers: 46 funds closed out of QGEN and 40 opened new positions — a net loss of 6 holders — while 95 trimmed existing stakes and 105 added.
The largest buyer was Citadel Advisors, adding an estimated $70.1M. The largest seller was Schroder Investment Management Group, exiting entirely with an estimated $326M sold.
- 292 institutional investors held Qiagen (QGEN) as of Q1 2022, down from 300 in Q4 2021.
- Funds reported $6.38B of Qiagen stock for Q1 2022, down 14% quarter-over-quarter.
- 40 funds opened new Qiagen positions in Q1 2022 and 46 closed out, a net change of -6 holders.
- The largest Qiagen buyer in Q1 2022 was Citadel Advisors, an estimated $70.1M added.
- The largest Qiagen seller in Q1 2022 was Schroder Investment Management Group, an estimated $326M sold.
Based on aggregated 13F filings for Q1 2022.